Abstract
Data alteration requires consideration of: what are data, when should they be available and what is their quality. Alteration may be intended or unintended: scientific misconduct, scientific error, use of questionable research practices, or community-based and cultural interpretations of data relevance. Situations in which data alteration are at risk include those in which conflict of interest (and thus potential for bias) is endemic, and those in which powerful incentives that do not support research integrity are present. Consequences of intentional and unintentional data alteration are morally important but are not uniformly addressed. Norm and governance changes from the current system are in initial stages of development and must address issues of the data revolution. Points of decision address ethical concerns and moral quandaries researchers will likely face in a system of research practice that does not comprehensively support research integrity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Accounting for sex and gender makes science better. (2020). Nature, 588, 196.
Amsterdam, J., et al. (2017). Industry-corrupted psychiatric trials. Psychiatria Polska, 51(6), 993–1008.
Anderson, L., & Wray, K. (2019). Detecting errors that result in retractions. Social Studies of Science, 49(6), 942–954.
Artino, A., Driessen, E., & Maggio, L. (2019). Ethical shades of gray: International frequency of scientific misconduct and questionable research practices in health professions education. Academic Medicine, 94(1), 76–84.
Asknes, D., Langfeldt, L., & Wouters, P. (2019). Citations, citation indicators, and research quality: An overview of basic concepts and theories. SAGE Open, 9, 1–17.
Avenell, A., et al. (2019). An investigation into the impact and implications of published papers from retracted research: Systematic search of affected literature. BMJ Open, 9, e031909.
Barnett, A., Zardo, P., & Graves, N. (2018). Randomly auditing research labs could be an affordable way to improve research quality: A simulation study. PLoS One, 13(4), e0195613.
Berggren, C., & Karabag, S. (2019). Scientific misconduct at an elite medical institute: The role of competing institutional logics and fragmented control. Research Policy, 48, 428–443.
Boulbes, D., et al. (2018). A survey on data reproducibility and the effect of publication process on the ethical reporting of laboratory research. Clinical Cancer Research, 24(14), 3447–3455.
Brown, A., et al. (2018). Issues with data and analyses: Errors, underlying themes and potential solutions. PNAS, 115(11), 2563–2570.
Bruton, S., et al. (2020). Personal motivations and systemic incentives: Scientists on questionable research practices. Science and Engineering Ethics, 26, 1531–1547.
Buchanan, A. (2009). Philosophy and public policy: A role for social moral epistemology. Journal of Applied Philosophy, 26(3), 276–290.
Bunkle, P. (2015). Correcting error in academic publishing: An ethical responsibility. Bioethical Inquiry, 12, 665–673.
Byrne, J., et al. (2019). Possibility of systemic research fraud targeting under-studied human genes: Causes, consequences, and potential solutions. Biomarker Insights, 14, 1–12.
Carlisle, J. (2017). Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals. Anaesthesia, 72, 944–952.
Carlisle, J. (2021). False individual patient data and zombie randomized controlled trials submitted to Anaesthesia. Anaesthesia, 76(4), 472–479.
Catillon, M. (2019). Trends and predictors of biomedical research quality, 1990-2015: A meta-research study. BMJ Open, 9, e030342.
Chevrier, R., et al. (2019). Use and understanding of anonymization and de-identification in the biomedical literature: Scoping review. Journal of Medical Internet Research, 21(5), e13484.
Davies, S. (2019). An ethics of the system: Talking to scientists about research integrity. Science and Engineering Ethics, 25(4), 1235–1253.
de Vries, Y., et al. (2019). Hiding negative trials by pooling them: A secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials. Psychological Medicine, 49(12), 2020–2026.
Douglas, H. (2014). The moral terrain of science. Erkenntnis, 79, 961–979.
Edwards, A. (2016). Team up with industry. Nature, 531, 299–301.
Elliott, C. (2017). The anatomy of research scandals. The Hastings Center Report, 47(3) inside back cover.
Enriquez, J. (2020). Right wrong: How technology transforms our ethics. MIT Press.
Fusenig, N., et al. (2017). The need for a worldwide consensus for cell line authentication: Experience implementing a mandatory requirement at the International Journal of Cancer. PLoS Biology, 15(4), e2001438.
Hand, D. (2020). Dark Data. Princeton University Press.
Hardwicke, T., et al. (2020). Calibrating the scientific ecosystem through meta-research. The Annual Review of Statistics and Its Application, 7, 11–37.
Holman, B., & Elliott, K. (2018). The promise and perils of industry-funded science. Philosophy Compass, 13, e12544.
Hosseini, M., et al. (2018). Doing the right thing: A qualitative investigation of retraction due to unintentional error. Science and Engineering Ethics, 24, 189–206.
Jones, D., Grady, C., & Lederer, S. (2016). “Ethics and clinical research” – The 50th anniversary of Beecher’s bombshell. The New England Journal of Medicine, 374, 2393–2398.
Kahan, B., et al. (2020). Public availability and adherence to prespecified statistical analysis approaches was low in published randomized trials. Journal of Clinical Epidemiology, 128, 29–34.
Kingori, P., & Gerrets, R. (2016). Morals, morale and motivations in data fabrication: Medical research fieldworkers’ views and practices in two Sub-Saharan African context. Social Science & Medicine, 166, 150–159.
Kingori, P., & Gerrets, R. (2019). The masking and making of fieldworkers and data in postcolonial global health research contexts. Critical Public Health, 29(4), 494–507.
Labbe, C., et al. (2020). Flagging incorrect nucleotide sequence reagents in biomedical papers: To what extent does the leading publication format impede automatic error detection? Scientometrics, 124, 1139–1156.
Leonelli, S. (2017). Global data quality assessment and the situated nature of “best” research practices in biology. Data Science Journal, 16(32), 1–11.
Leonelli, S. (2019). The challenges of big data biology. eLife, 8, 47381.
Osipenko, L. (2019). Blockchain’s potential to improve clinical trials – An essay by Leeza Osipenko. BMJ, 367, l5561.
Sacco, D., et al. (2018). In defense of the questionable: Defining the basis of research scientists’ engagement in questionable research practices. Journal of Empirical Research on Human Research Ethics, 13(1), 101–110.
Sacco, D., et al. (2019). Grounds for ambiguity: Justifiable bases for engaging in questionable research practices. Science and Engineering Ethics, 25(5), 1321–1337.
Schickore, J., & Hangel, N. (2019). “It might be this, it should be that…” uncertainty and doubt in day-to-day research practice. The European Journal of Philosophy of Science, 9, 31.
Seife, C. (2015). Research misconduct identified by the US Food and Drug Administration; Out of sight, out of mind, out of the peer reviewed literature. JAMA Internal Medicine, 175(4), 567–577.
Smaldino, P., & McElreath, R. (2016). The natural selection of bad science. Royal Society Open Science, 3(9), 160384.
Tadros, V. (2020). Distributing responsibility. Philosophy & Public Affairs, 48(3), 223–261.
Wager, E. (2020). Why we could stop worrying about gaming metrics if we stopped using journal articles for publishing scientific research. In M. Biagioli & A. Lippman (Eds.), Gaming the metrics: Misconduct and manipulation in academic research. MIT Press.
Wallach, J., et al. (2018). Research, regulatory and clinical decision-making: The importance of scientific integrity. Journal of Clinical Epidemiology, 93, 88–93.
Williams, C., et al. (2019). Figure errors, sloppy science and fraud: Keeping eyes on your data. The Journal of Clinical Investigation, 129(5), 1805–1807.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Redman, B.K. (2023). Data Alteration. In: Valdés, E., Lecaros, J.A. (eds) Handbook of Bioethical Decisions. Volume II. Collaborative Bioethics, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-031-29455-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-29455-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-29454-9
Online ISBN: 978-3-031-29455-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)